| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/JCP.25361 |
| P698 | PubMed publication ID | 26919443 |
| P2093 | author name string | Ankur Bhowal | |
| Sanghamitra Sengupta | |||
| Sanmitra Basu | |||
| Subhadipa Majumder | |||
| Pritha Mukherjee | |||
| Urmi Chatterji | |||
| P2860 | cites work | East meets West: ethnic differences in prostate cancer epidemiology between East Asians and Caucasians | Q26827438 |
| Molecular mechanisms of epithelial-mesenchymal transition | Q27013743 | ||
| Cancer statistics, 2013 | Q27860762 | ||
| TGFbeta signaling in growth control, cancer, and heritable disorders | Q28142605 | ||
| TGFβ signalling in context | Q28275410 | ||
| TGFbeta in Cancer | Q28288866 | ||
| Comparative analysis of TGF-β/Smad signaling dependent cytostasis in human hepatocellular carcinoma cell lines | Q31132600 | ||
| E2F5 status significantly improves malignancy diagnosis of epithelial ovarian cancer | Q33533979 | ||
| E2f1-3 switch from activators in progenitor cells to repressors in differentiating cells | Q33589421 | ||
| Two faces of TGF-beta1 in breast cancer | Q33661529 | ||
| Context-dependent transcriptional regulation | Q33748147 | ||
| TGF-β-induced growth inhibition in B-cell lymphoma correlates with Smad1/5 signalling and constitutively active p38 MAPK | Q33752152 | ||
| TGF- β: an important mediator of allergic disease and a molecule with dual activity in cancer development | Q33809976 | ||
| Signaling of transforming growth factor-beta family members through Smad proteins | Q34098846 | ||
| Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter | Q34323096 | ||
| Expression of transcription factor E2F1 induces quiescent cells to enter S phase | Q34354875 | ||
| Tgf-beta induced Erk phosphorylation of smad linker region regulates smad signaling | Q34374221 | ||
| TGF-beta control of cell proliferation | Q34441563 | ||
| Gleason 6 Prostate Cancer: Translating Biology into Population Health | Q34470640 | ||
| Wide-ranging functions of E2F4 in transcriptional activation and repression revealed by genome-wide analysis | Q34947016 | ||
| Emerging roles of E2Fs in cancer: an exit from cell cycle control | Q35009182 | ||
| Overexpression of E2F mRNAs associated with gastric cancer progression identified by the transcription factor and miRNA co-regulatory network analysis | Q35043503 | ||
| A mechanism of repression of TGFbeta/ Smad signaling by oncogenic Ras | Q35193411 | ||
| The association of benign prostatic hyperplasia and cancer of the prostate | Q35321403 | ||
| Overexpression of E2F1 in human gastric carcinoma is involved in anti-cancer drug resistance | Q35481434 | ||
| Mechanism and regulation of nucleocytoplasmic trafficking of smad | Q35799545 | ||
| Duel nature of TGF-beta signaling: tumor suppressor vs. tumor promoter | Q35988691 | ||
| Benign prostatic hyperplasia: age-related tissue-remodeling | Q36069075 | ||
| The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma | Q36227180 | ||
| Crosstalk mechanisms between the mitogen-activated protein kinase pathways and Smad signaling downstream of TGF-beta: implications for carcinogenesis. | Q36241249 | ||
| Role of TGFbeta in skin inflammation and carcinogenesis | Q36468001 | ||
| The pleiotropic roles of transforming growth factor beta in homeostasis and carcinogenesis of endocrine organs | Q36489880 | ||
| Deconstructing the mechanisms and consequences of TGF-β-induced EMT during cancer progression | Q37044614 | ||
| TGFbeta-mediated formation of pRb-E2F complexes in human myeloid leukemia cells | Q37092586 | ||
| Overexpression of E2F-5 correlates with a pathological basal phenotype and a worse clinical outcome | Q37123533 | ||
| Transforming growth factor beta: tumor suppressor or promoter? Are host immune cells the answer? | Q37326107 | ||
| Is there evidence of a relationship between benign prostatic hyperplasia and prostate cancer? Findings of a literature review | Q37332536 | ||
| Spectrum of prostatic lesions. | Q37362008 | ||
| More than an accessory: implications of type III transforming growth factor-beta receptor loss in prostate cancer | Q37672642 | ||
| Role of Smads in TGFβ signaling | Q37885217 | ||
| The roles of TGF-β signaling in carcinogenesis and breast cancer metastasis | Q37964588 | ||
| TGF-β signaling and epithelial-mesenchymal transition in cancer progression | Q38063807 | ||
| Smad phospho-isoforms direct context-dependent TGF-β signaling | Q38122890 | ||
| Prostate cancer in Asian men. | Q38193300 | ||
| Transforming growth factor-β stimulates human ovarian cancer cell migration by up-regulating connexin43 expression via Smad2/3 signaling | Q38851786 | ||
| Analysis of genetic aberrations on chromosomal region 8q21-24 identifies E2F5 as an oncogene with copy number gain in prostate cancer. | Q39200185 | ||
| Specific interactions between Smad proteins and AP-1 components determine TGFβ-induced breast cancer cell invasion. | Q39290041 | ||
| A potential oncogenic role of the commonly observed E2F5 overexpression in hepatocellular carcinoma | Q39601497 | ||
| Effect of verification bias on screening for prostate cancer by measurement of prostate-specific antigen | Q39655731 | ||
| SKI promotes Smad3 linker phosphorylations associated with the tumor-promoting trait of TGFbeta | Q39726558 | ||
| Transforming growth factor-{beta}-inducible phosphorylation of Smad3 | Q39883712 | ||
| EMT or apoptosis: a decision for TGF-beta | Q40147080 | ||
| TGF-beta and HGF transmit the signals through JNK-dependent Smad2/3 phosphorylation at the linker regions | Q40522842 | ||
| TGF beta in prostate cancer: a growth inhibitor that can enhance tumorigenicity | Q41435322 | ||
| c-Jun N-terminal kinase 1 promotes transforming growth factor-β1-induced epithelial-to-mesenchymal transition via control of linker phosphorylation and transcriptional activity of Smad3. | Q42066518 | ||
| The TGF-β-Smad3 pathway inhibits CD28-dependent cell growth and proliferation of CD4 T cells | Q43686523 | ||
| Profiling molecular targets of TGF-beta1 in prostate fibroblast-to-myofibroblast transdifferentiation | Q44320388 | ||
| Attenuation of the TGF-beta-Smad signaling pathway in pancreatic tumor cells confers resistance to TGF-beta-induced growth arrest. | Q44475259 | ||
| p38 MAPK mediates fibrogenic signal through Smad3 phosphorylation in rat myofibroblasts | Q44598575 | ||
| Smad3 and Smad3 phosphoisoforms are prognostic markers of gastric carcinoma. | Q44862683 | ||
| Association of clinical benign prostate hyperplasia with prostate cancer incidence and mortality revisited: a nationwide cohort study of 3,009,258 men. | Q46173080 | ||
| Transforming growth factor (TGF)-beta1 stimulates pulmonary fibrosis and inflammation via a Bax-dependent, bid-activated pathway that involves matrix metalloproteinase-12. | Q50232161 | ||
| Characterization of E2F3a function in HepG2 liver cancer cells | Q53303550 | ||
| Smad2 and Smad3 phosphorylated at both linker and COOH-terminal regions transmit malignant TGF-beta signal in later stages of human colorectal cancer. | Q53389037 | ||
| Smad2/3 linker phosphorylation is a possible marker of cancer stem cells and correlates with carcinogenesis in a mouse model of colitis-associated colorectal cancer. | Q53531646 | ||
| P433 | issue | 11 | |
| P921 | main subject | prostate cancer | Q181257 |
| P304 | page(s) | 2482-2492 | |
| P577 | publication date | 2016-02-25 | |
| P1433 | published in | Journal of Cellular Physiology | Q1524270 |
| P1476 | title | Deregulated E2F5/p38/SMAD3 Circuitry Reinforces the Pro-Tumorigenic Switch of TGFβ Signaling in Prostate Cancer | |
| P478 | volume | 231 |
| Q58562069 | Deciphering genetic regulation of CD14 by SP1 through characterization of peripheral blood mononuclear transcriptome of P. faiciparum and P. vivax infected malaria patients |
| Q90733821 | Dual-functionality of RASSF1A overexpression in A375 cells is mediated by activation of IL-6/STAT3 regulatory loop |
| Q92835211 | Effects of miR-129-3p on biological functions of prostate cancer cells through targeted regulation of Smad3 |
| Q41547606 | MicroRNA-1179 inhibits glioblastoma cell proliferation and cell cycle progression via directly targeting E2F transcription factor 5. |
| Q41548014 | Pathway-based expression profiling of benign prostatic hyperplasia and prostate cancer delineates an immunophilin molecule associated with cancer progression |
| Q90150229 | Scientific reports concerning the impact of interleukin 4, interleukin 10 and transforming growth factor β on cancer cells |
Search more.